Searched for
ASTRAZENECA SUN PHARMA
AstraZeneca Pharma India shares surge over 3% on new Hyperkalaemia drug deal with Sun PharmaOn Tuesday, shares of AstraZeneca Pharma India surged following the announcement of an exciting alliance with Sun Pharmaceutical Industries...- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- Over 3k brands hit pharma mkt, cancer drug tops in salesIndia's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, ref...
- AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep SinghAnglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...
- Sun Pharma acquires rights to trademarks of three diabetes drug brands in India from AstraZeneca"Sun Pharma has now acquired the rights to trademarks Oxra, Oxramet and Oxraduo in India from AstraZeneca AB, Sweden, parent company of Ast...
- Rs 50,000 crore support boosts pharma counters, index up 4%Several pharmaceuticals and healthcare stocks including Shilpa Medicare, Aarti Drugs, Granules, Narayana Hrudayalaya, Astrazeneca Pharma, B...
- Share market update: 63 stocks hit 52-week highs on NSEOverall, 37 shares were trading in green in Nifty50 index, while 12 were trading in red in the afternoon trade.
- COVID-19: Infections rise, so do vaccine trialsEver since the Covid-19 outbreak late last year, the world has been moving much faster with regards to working on a vaccine and a possible ...
- Share market update: 10 stocks hit 52-week highs on NSERuchi Soya Inds, AstraZeneca and Torrent Power hit their fresh 52-week high during the day.
- Sun Pharma rallies 4% on pact to launch cancer drugs in ChinaThe agreement will help bring cost effective and quality drugs to patients in China.
- Share market update: Bajaj Finserv, Bajaj Finance, Page Industries among stocks that touch 52-week highsThe NSE Nifty50 index was down 17 points at 10,804, while the BSE Sensex was 70 points down at 35,620 around 11:55 am.
- Sun Pharma, AstraZeneca tie up to sell latest anti-diabetes drug DapagliflozinDiabetes estimated to affect approximately 69.2 million people in India and more than 415 million people worldwide.
- Yashwant Mahadik to lead Sun Pharma's HR teamMahadik, 48, was senior vice president - global head of human resources business, transformation, IT and operations of Philips.
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
- Sun Pharma, AstraZeneca seal distribution dealThe drug majors have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in Ind...
- Earnings, ANDA approvals to supplement pharma stocks: Neeraj Deewan, Quantum SecuritiesA continuous improvement in earnings on sequential basis will continue and pharma stocks may keep on performing well, believes Quantum Secu...
- M&A buzz drawing interest to the pharma sector: Deven ChokseyMost pharma companies want to build a pipeline and at the same time also want to bring down the cost for them, and in turn build up profita...
- Lupin, Dr Reddy's, Sun Pharma get USFDA nod for mental disorder drugThree drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablet...
- Sun Pharma gets US nod for prostate cancer drugSun Pharmaceutical Industries Ltd said on Tuesday that it had received approval from the US Food and Drug Administration to launch generic ...
- Ranbaxy gets tentative FDA nod for ulcer drugNexium is the second largest selling drug in the world and has annual sales of $5.5 billion in the US market alone.
Load More
